Department of Pediatrics

Patrick receives award for children’s health research

Stephen Patrick, MD, MPH, MS, director of the Vanderbilt Center for Child Health Policy, has been awarded the fifth annual Gale and Ira Drukier Prize in Children’s Health Research.

Post-transplant complication

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.

Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.

Racial Equity Task Force co-chairs named

Three co-chairs have been named to lead a new Racial Equity Task Force, which is charged with identifying barriers to and opportunities for achieving racial equity at Vanderbilt University Medical Center and Vanderbilt University School of Medicine (VUSM).

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.

1 15 16 17 18 19 42